https://www.avient.com/sites/default/files/2022-07/Lewiston 308872_en_13485_21%5B43%5D.pdf
Müller, CEO SQS
41
7
0
_
2
/ J
u
n
e
2
0
19
/ V
er
si
o
n
2
.0
A.
https://www.avient.com/products/thermoplastic-elastomers/versaflex-hc-thermoplastic-elastomers
COVID-19 Containment Tube Screw Caps
https://www.avient.com/investor-center/news/avient-provides-third-quarter-2020-performance-update
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include the impact the COVID-19 pandemic has on our business, results from operations, financial condition and liquidity; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's Masterbatch business, including any expected synergies; our ability to successfully integrate Clariant's Masterbatch business and achieve the expected results of the acquisition of Clariant's Masterbatch business, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisitions and integration, working capital reductions, costs reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
https://www.avient.com/investor-center/news/avient-announces-agreement-acquire-dsm-protective-materials-dyneema-and-plans-explore-sale-distribution
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: the time required to consummate the acquisition of the Dyneema business; the satisfaction or waiver of conditions in the purchase agreement; completion of the consultation process with the relevant Dutch works council; the ability to obtain required regulatory or other third-party approvals and consents and otherwise consummate the proposed acquisition of the Dyneema business; our ability to achieve the strategic and other objectives relating to the proposed acquisition of the Dyneema business and possible sale of the distribution business; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-june-2021-w-non-gaap-recs_0.pdf
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
• Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
• The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
• The current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows;
• Our ability to achieve the strategic and other objectives relating to the acquisition of Clariant’s Masterbatch business, including any expected synergies;
• Changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business;
• Fluctuations in raw material prices, quality and supply, and in energy prices and supply;
• Production outages or material costs associated with scheduled or unscheduled maintenance programs;
• Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
• An inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals;
• Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
• Information systems failures and cyberattacks;
• Our ability to consummate and successfully integrate acquisitions;
• Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; and
• Other factors described in our Annual Report on Form 10-K for the year ended December 31, 2020 under Item 1A, “Risk Factors.”
This
innovation drives performance and is
reflective of consistent, strategic
investments in our portfolio…and
people.
2020 Pro forma $991 $86
Sustainable Solutions 15 11% 6
Healthcare 28 22% 6
Composites 6 10% 3
Growth in Emerging Regions 44 30% 10
Other 53 10% 7
Sub-total $1,137 15% $118
FX Impact 25 - 2
Synergies - - 11
Incentives, Travel, Other Employee Costs - - (8)
2021 Actual $1,162 17% $123
Q1 2021 ORGANIC SALES AND OPERATING INCOME
( T O TA L C O M PA N Y )
18
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
Sales Growth Rate
Adjusted
Operating
Income$ millions
(1)
19
Electrical &
Electronics
Building &
Construction
Wire & Cable Transportation Industrial Healthcare Packaging Consumer
Q1 2020PF Q1 2021
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
(2) Financial information is presented on a constant currency basis
(1,2)
(42% of total revenue)
(58% of total revenue)
Q1 END MARKET SALES PERFORMANCE
+17%
+14% +8%
+10%
+8% +22%
+5%
+24%
Q 2 A N D F U L L Y E A R
2 0 2 1 O U T L O O K
A S O F A P R I L 3 0 , 2 0 2 1 W E B C A S T
$69
$112
2020PF 2021E
$0.42
$0.80
2020PF 2021E
ORGANIC GROWTH PROJECTIONS – Q2
( T O TA L C O M PA N Y )
21
Sales Adjusted Operating Income
$870
$1,100
2020PF 2021E
+ 26%
Adjusted EPS
+ 62% + 90%
(in millions) (in millions)
(1) (1) (1)
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
FULL YEAR GUIDANCE INCREASED
22
Sales Adj.
In 2021, we expect substantial earnings growth and strong cash flow generation as we emerge from the
COVID-19 pandemic.
https://www.avient.com/sites/default/files/2022-09/Additives and Colorants for Stadium and Arena Seats Application Bulletin.pdf
COLOR RAL REFERENCE COLOR RAL REFERENCE
1015 Brown/12 6026 Green/14
1034 Yellow/14 6032 Green/20
1018 Yellow/19 7004 Grey/21
1003 Yellow/20 8025 Brown/14
3020 Red/15 9022 Pearl Grey/1
5005 Blue/35 9010 White/5
5000 Blue/36
https://www.avient.com/sites/default/files/resources/US_North%2520Baltimore_RC14001_2020Exp.pdf
has been assessed by ABSQuality Evaluations,Inc. and found to be in conformance with the requirements set forth by:
RC14001®:2015
DESIGN AND MANUFACTURE OF CUSTOM PVC COMPOUNDS
Certificate No: 55421
Effective Date: 20 November 2017
Expiration Date: 19 November 2020
Issue Date: 20 November 2017 Alex Weisselberg, President
Validity of this certificate is based on the successful completion of the periodic surveillance audits of the management syst em defined by the above scope and is contingent upon
prompt,written notification to ABS Quality Evaluations, Inc. of significant changes to the management system or components thereof.
https://www.avient.com/sites/default/files/2023-12/Jeddah%2C Saudia Arabia ISO 14001.pdf
Limited
PO Box 2137, Jeddah 22758
Saudi Arabia
Has been assessed and found to meet the requirements of
ISO 14001:2015
This certificate is valid for the following scope of operations:
Production and Supply of Color and Additive Master Batches
Authorised by: Stan Wright
Director
Date of Certificate Issue: 20 December 2022
Certificate Valid Until: 19 December 2025
Recertification audit before 20 November 2025.
https://www.avient.com/sites/default/files/2024-02/Santa Clara_ISO22000.pdf
Müller, CEO SQS
6
6
6
0
_
2
/ J
u
n
e
2
0
19
/ V
er
si
o
n
2
.0
Swiss Association for Quality
and Management Systems (SQS)
Bernstrasse 103, 3052 Zollikofen, Switzerland
A.
https://www.avient.com/sites/default/files/2020-12/resound-om-technical-bulletin_0.pdf
Peel, PLI 12 19 23 20 19
reSound OM 5510 for PP
reSound OM 5510-60N Room Temperature 70C
1 day 1 week 2 weeks 6 months 1 week 2 weeks 3 weeks
Bio-derived Content (%) 50% 50% 50% 50% 50% 50% 50%
Hardness, Shore A 60 60 60 60 60 60 60
Specific Gravity 0.89 0.89 0.89 0.89 0.89 0.89 0.90
50% Modulus, PSI 247 241 244 251 234 244 240
100% Modulus, PSI 343 333 338 339 321 331 326
Tensile Strength, PSI 625 621 647 610 633 662 642
Elongation, % 306 314 309 313 312 315 315
Tear Strength, PLI 109 108 113 113 111 117 115
reSound OM 5520-55N Room Temperature 70C
1 day 1 week 2 weeks 6 months 1 week 2 weeks 3 weeks
Bio-derived Content (%) 49% 49% 49% 49% 49% 49% 49%
Hardness, Shore A 54 54 55 55 54 55 56
Specific Gravity 0.95 0.95 0.96 0.96 0.95 0.96 0.96
50% Modulus, PSI 258 256 256 265 266 271 257
100% Modulus, PSI 353 355 357 362 373 379 367
Tensile strength, PSI 637 615 637 669 651 674 642
Elongation, % 319 315 319 333 313 319 315
Tear Strength, PLI 146 136 133 142 137 138 141
reSound OM 5510-45N Room Temperature 70C
1 day 1 week 2 weeks 6 months 1 week 2 weeks 3 weeks
Bio-derived Content (%) 40% 40% 40% 40% 40% 40% 40%
Hardness, Shore A 45 46 47 46 46 45 45
Specific Gravity 0.88 0.89 0.89 0.89 0.89 0.89 0.90
50% Modulus, PSI 153 158 154 162 137 136 133
100% Modulus, PSI 251 259 259 261 226 222 218
Tensile Strength, PSI 438 481 451 495 417 470 486
Elongation, % 215 240 211 243 204 227 238
Tear Strength, PLI 84 81 87 82 83 85 84
AGING – PROPERTY RETENTION
• Tested at room temperature and 70° C for comparison • Hardness, tensile strength elongation and modulus
showed great retention
Overmolding onto PP
Overmolding onto ABS
RHEOLOGY
Suitable for injection molding and overmolding
1.0
10 100 1000 10000 100000
10.0
100.0
1000.0
reSound OM 5510-30N
reSound OM 5510-45N
reSound OM 5510-60N
reSound OM 5510-70N
Shear Rate, 1/s
C
ap
ill
ar
y
Vi
sc
os
it
y,
P
a*
s
1.0
10 100 1000 10000 100000
10.0
100.0
1000.0
reSound OM 5520-55N
Shear Rate, 1/s
C
ap
ill
ar
y
Vi
sc
os
it
y,
P
a*
s
Capillary viscosity at 200°C
Capillary viscosity at 200°C
reSound OM 5510 for PP
reSound OM 5520 for ABS
www.avient.com
Copyright © 2020, Avient Corporation.